Ramucirumab is a human VEGFR-2 антагонист for the treatment of solid tumors. Ramucirumab is a recombinant human immunoglobulin G1 моноклональный антитело that binds to the extracellular связывание domain of VEGFR-2 and prevents the связывание of VEGFR ligands: VEGF
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors. Ramucirumab is a recombinant human immunoglobulin G1 monoclonal antibody that binds to the extracellular binding domain of VEGFR-2 and prevents the binding of VEGFR ligands: VEGF
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.